New drug aims to sharpen the mind in schizophrenia
Symptom relief
Recruiting now
This study is testing whether a new drug called KYN-5356 can help improve thinking, memory, and concentration in adults with schizophrenia. About 150 participants will live in a clinic for about a month to receive either the drug or a placebo, alongside their regular medication. …
Phase: PHASE2 • Sponsor: Kynexis B.V. • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC